The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

Completion of preclinical data package for RAD 402

by admin December 10, 2024
December 10, 2024
Completion of preclinical data package for RAD 402

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Lundin Mining to Divest Neves-Corvo and Zinkgruvan Operations for US$1.52 Billion
next post
CLEO Further Expands Ovarian Cancer Trial with Siles Health

Related Posts

Boliden Strikes C$20 Million Deal with Golden Sky...

September 5, 2025

Stallion Uranium Completes First Tranche of Non-Brokered Private...

August 21, 2025

Top Altcoins to Watch in 2025: An Investor’s...

January 28, 2025

Experts Warn of Supply Cliff for Battery Raw...

February 14, 2024

5 Top Canadian Oil and Gas Dividend Stocks...

November 1, 2024

Victory Battery Metals Corp. Options Kachiwiss Uranium Project...

April 19, 2024

Heritage Mining Announces Closing of Strategic Investment

May 15, 2025

Crypto Market Recap: Coinbase Challenges Tornado Sanctions Decision

March 25, 2025

Top 5 Junior Copper Stocks on the TSXV...

April 17, 2025

Ontario Tables Sweeping Bill to Restrict Foreign Access...

May 3, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,550)
    • Investing (4,201)
    • Politics (5,579)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved